IRIS
ZANGHI', Mariangela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.769
NA - Nord America 2.377
AS - Asia 1.076
SA - Sud America 279
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 37
OC - Oceania 1
Totale 6.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.318
RU - Federazione Russa 1.395
SG - Singapore 433
CN - Cina 356
SE - Svezia 313
IE - Irlanda 289
BR - Brasile 249
IT - Italia 238
HK - Hong Kong 116
DE - Germania 107
FR - Francia 96
UA - Ucraina 88
GB - Regno Unito 71
PL - Polonia 58
FI - Finlandia 50
VN - Vietnam 47
IN - India 33
CA - Canada 24
BE - Belgio 23
AR - Argentina 12
ZA - Sudafrica 12
MX - Messico 9
BD - Bangladesh 8
PK - Pakistan 8
CO - Colombia 7
IL - Israele 7
IQ - Iraq 7
JP - Giappone 7
NL - Olanda 7
TR - Turchia 7
ES - Italia 6
MA - Marocco 6
SC - Seychelles 6
NO - Norvegia 5
PH - Filippine 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
ET - Etiopia 4
JO - Giordania 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
DZ - Algeria 3
EC - Ecuador 3
GT - Guatemala 3
HN - Honduras 3
ID - Indonesia 3
IR - Iran 3
JM - Giamaica 3
LT - Lituania 3
MY - Malesia 3
NI - Nicaragua 3
BG - Bulgaria 2
BS - Bahamas 2
BY - Bielorussia 2
GP - Guadalupe 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AT - Austria 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.542
Salva come PNG Salva come JPEG
Città #
Moscow 382
Ashburn 317
Dublin 287
Singapore 245
Chandler 212
Dallas 197
Nyköping 169
Jacksonville 166
San Jose 142
Beijing 129
Hong Kong 116
Ann Arbor 72
The Dalles 70
Council Bluffs 64
New York 59
Warsaw 56
Los Angeles 52
Dearborn 47
Messina 42
Medford 40
Princeton 40
Cambridge 39
Des Moines 36
Lauterbourg 35
Boardman 29
Munich 27
Brussels 23
São Paulo 23
Woodbridge 23
Buffalo 21
Tianjin 20
Lancaster 19
Ho Chi Minh City 17
San Mateo 17
Jinan 15
Chicago 14
Wilmington 14
Brooklyn 13
Pune 12
Santa Clara 12
Frankfurt am Main 11
Hebei 11
Houston 10
Orem 10
Zhengzhou 10
Guangzhou 9
Montreal 9
Nanjing 9
Rio de Janeiro 9
Taizhou 9
Atlanta 8
Columbus 8
Denver 8
Hanoi 8
Johannesburg 8
Phoenix 8
Shenyang 8
Turku 8
London 7
Seattle 7
Stockholm 7
Belo Horizonte 6
Chennai 6
Düsseldorf 6
Manchester 6
Nanchang 6
Ningbo 6
Redondo Beach 6
San Francisco 6
Amsterdam 5
Brasília 5
Haiphong 5
Hangzhou 5
Las Vegas 5
Leawood 5
Monmouth Junction 5
Mumbai 5
Rome 5
Tokyo 5
Addis Ababa 4
Amman 4
Auburn Hills 4
Augusta 4
Boston 4
Calgary 4
Jiaxing 4
Medellín 4
Miami 4
Milan 4
Oslo 4
Ribeirão Preto 4
San José 4
Tashkent 4
Toronto 4
Baku 3
Barnet 3
Belém 3
Bremen 3
Brockport 3
Changsha 3
Totale 3.671
Salva come PNG Salva come JPEG
Nome #
Linfoscintigrafia ascellare preoperatoria nel cancro della mammella. 334
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 252
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 230
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 223
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 214
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 192
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 191
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 188
INCIDENZA DELL'ONCOTIPO POLMONARE NELLO STESSO TERRITORIO IN TRIENNI DIFFERENTI- 1983/84/85 E 1993/94/95. Eur. Jour. of Oncology Vol. 2, n° 4, 1997. 185
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 183
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study 179
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 177
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 175
Second line chemoterapy in patients with metastatic colorectal cancer(MCRC):our experience 173
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 171
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 166
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival. 164
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 164
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 163
IL-33/IL-31 axis: A new pathological mechanism for epidermal growth factor receptor tyrosine kinase inhibitors-associated skin toxicity? 161
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 160
Incidenza dell’oncotipo polmonare nello stesso territorio in trienni differenti 1983/84/85 e 1993/94/95. 159
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 159
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 157
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 156
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 156
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 155
Impact of single-nucleotide polymorphisms in genes coding for folate pathway enzymes on efficacy/toxicity of gemcitabine and pemetrexed based therapy in advanced non small cell lung cancer (NSCLC): new prospectives for old markers. 147
NSCLC and HER2: between lights and shadows 141
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. 133
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience. 131
LINFOSCINTIGRAFIA ASCELLARE PREOPERATORIA DEL CANCRO DELLA MAMMELLA. Acta Oncologica - Voi. XVI – n. 1, 1995. 129
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status. 127
OUR EXPERIENCE ON THE EFFECTS OF TAMOXIFEN ON BLOOD COAGULATION IN PATIENTS OPERATED FOR BREAST CANCER Folia Oncologica vol.XIV-n.2-3 (Aprile-Settembre)-1991 126
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 124
Induction chemotherapy to weekly paclitaxel concurrent with curative radiotherapy in stage IV (MO) unresectable head and neck squamous cell carcinoma: a dose escalation study 117
PHASE II STUDY OF LIPOSOMAL DOXORUBICIN AND GEMCYTABINE IN THE TREATMENT OF RECURRENT OVARIAN CANCER 115
Safety of Zoledronic acid in bone metastatic breast cancer patients: A retrospective analysis. 106
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 103
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 69
null 22
Totale 6.577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022255 0 0 0 0 6 1 25 9 3 86 40 85
2022/2023879 70 93 39 68 65 77 7 69 363 0 20 8
2023/2024227 20 42 7 24 12 81 14 14 0 4 0 9
2024/2025793 6 7 14 52 27 29 7 145 210 55 68 173
2025/20262.827 164 147 185 135 226 654 374 388 384 97 36 37
2026/2027355 27 85 100 101 42 0 0 0 0 0 0 0
Totale 6.577